We've merged with Palleos Healthcare to form a wide-reaching European CRO.
Find out more
OCT Clinical Team has recently published its blog article at Applied Clinical trials. The article reveals the survey results fielded among OCT Clinical’s customer and partner databases of over 8,000 contacts. The aim of the research was to explore the CRO-Sponsor collaboration scenarios and to identify key challenges, weak points, and best practices for each group.
Such surveys are aimed at creating a “win-win” approach for both parties. Sponsors would benefit from more robust and feasible plans, procedural efficiency, and decreased costs, while CROs would get an increasingly reliable and longer-term revenue stream by providing additional value and expanding its service offerings.
Read the full article and discover the survey results at Applied Clinical Trials official website.[1]
OCT Clinical is now operating under Palleos Healthcare brand name.
“The merger will undoubtedly create significant synergies, not just doubling but squaring the expertise of both companies”, Philip Räth, Ph.D., managing director at Palleos, said in the release.
“OCT Clinical is proud to join forces with palleos healthcare, as it has an excellent reputation in the industry it serves. Now we can offer tailored solutions to our clients to meet their diverse clinical research needs and accelerate the time of bringing their products to market”, Dmitry Sharov, CEO at OCT Clinical.
